HOME | ABOUT US | MEDIA KIT | CONTACT US | INQUIRE
HOME | ABOUT US | MEDIA KIT | CONTACT US | INQUIRE
The rising threat to a health-care system already under strain
PUBLISHED FEBRUARY 2026
As Mad Men’s Don Draper might have said: “It’s health care…but with trees!”
Indeed, there is a forest to explore in the regional health-care market. But those trees—issues facing health systems and providers, insurers and corporate HR executives come to mind—can at times mask a structural shift taking place. That’s happening on different levels, from rising clinical demand on one hand to tightening economic capacity on the other.
Among those trees: rising rates of chronic disease (cancer and obesity, in particular), aging demographics, workforce shortages, premium spikes, Medicaid churn and rural-provider fragility across the bistate region. The forest is this: Kansas City’s health-care system is entering a period where volume growth and financial strain are rising simultaneously. That tension will define the market far more than headline-grabbing updates on topics like Medicaid expansion.
For the first time in the nation’s history, more than 2 million people have been diagnosed with invasive cancer in a single year. That threshold—crossed in 2024 and projected to climb again in 2025—is not the result of a mysterious spike, nor a sudden biological event. The American Cancer Society’s annual projections show a steady rise from roughly 1.9 million new cases in 2021 to more than 2.04 million in 2025—an increase of about 7-8 percent in just four years. The curve is smooth, the drivers are known. The implications, though, are profound.
For health-care providers and payers in the bi-state region, this is not an abstract national statistic. It is a preview of the next decade.
Michael Main, senior vice president and chief clinical officer for BJC Health’s West Region at Saint Luke’s, sees that trajectory in real time. “Chronic disease volumes are increasing with the aging population—and this will continue for decades after the last Baby Boomer retires,” he says. The response, he adds, is not retrenchment. Saint Luke’s “is on a growth trajectory,” expanding its primary-care base alongside major service lines including cardiovascular care, oncology and neurosciences.
At the same time, leaders at The University of Kansas Cancer Center see the same growth curve refracted through a national lens. As an NCI-designated comprehensive cancer center, it draws patients from across the country seeking therapies not widely available elsewhere. Senior vice president Jack Beal says that while incidence continues to rise, “our ability to effectively treat cancer is improving at a dramatic rate,” particularly through newer modalities such as cellular therapy. A new cancer facility at 39th and Rainbow is being designed specifically around research and care in those advanced treatments—an example of adding capacity, but in a targeted, high-acuity way.
Keith Zimmerman, president of HCA Midwest Health, echoes the focus on innovation amid rising demand. As part of the HCA Healthcare Sarah Cannon Cancer Network, his system is expanding capacity not just through facilities but via efficient models and advanced technologies that serve as “force multipliers” for caregivers. HCA Midwest was the first in the region to offer histotripsy—a noninvasive, incisionless ultrasound treatment that liquefies liver tumors—enabling faster recovery and lower resource use. The system is also deploying AI for ambient clinical documentation and nurse handoff support to reduce administrative burdens and increase bedside time.
As for the data, there is no single villain buried within. Cancer mortality continues to decline overall, a testament to earlier detection and better treatment. What’s rising is incidence—partly because Americans are living longer, partly because the population is growing, partly because detection has improved, and partly because risk factors tied to obesity and lifestyle continue to exert pressure.
This is the paradox of progress: more cancer cases diagnosed, even as treatment improves. For hospital systems in Kansas and Missouri, that means oncology is becoming not just a clinical priority but a financial axis. Cancer care is resource-intensive. It requires infusion centers, imaging capacity, specialty physicians, nurse navigators, genetic counselors, and long-term follow-up infrastructure. It also tends to anchor downstream service lines—from surgery to cardiology to behavioral health.
In a metro region like Kansas City, where major systems compete for tertiary and quaternary care, oncology investment is not optional. It is strategic.
Specific cancer types with notable increases or unusual patterns post-2020 (based on ACS reports, trends, and related analyses):
Early-Onset Diseases
Yet the rising incidence is not confined to traditional older populations. That’s a huge consideration for employee health-benefit structures as those conditions spread among those still in the workforce.
Colorectal cancer among adults under 50 has been climbing for years. Breast cancer incidence is increasing. Uterine and endometrial cancers—often associated with obesity—are rising at some of the fastest rates among women. Pancreatic, kidney and melanoma trends are also edging upward.
These are not pandemic-era anomalies tied to exams and treatments deferred in 2020 and 2021. They are multi-decade shifts.
For employers and insurers, early-onset cancers change the actuarial picture. They affect people in their 30s and 40s—prime working years. They increase short-term disability claims, disrupt productivity, and add high-cost episodes into commercial insurance pools that historically skewed younger and healthier.
Jenny Housley, president of Blue KC, notes that two primary drivers of claim-cost trends are frequency and unit cost of services. When complex, high-cost conditions like cancer rise among working-age adults, it becomes a direct expense driver for employers—especially the two-thirds of U.S. employees covered by self-funded plans, where trends hit in real time. “It is important that they have a thoughtful health plan strategy which aligns to their risk tolerance,” she says.
For providers, they require rethinking screening messaging and outreach. Colonoscopy guidelines have already shifted younger. Breast-imaging conversations are evolving. Beal notes that part of the response is expanding specialized cancer-prevention services for higher-risk individuals and advancing more precise diagnostic tools, including genetic profiling of tumors. The aim is earlier detection and, where possible, intervention that may reduce the burden of more extensive treatment later, improving outcomes while moderating long-term costs.
Cancer, in other words, is no longer primarily a late-life event. It is increasingly a mid-career interruption.
And that intersects directly with the region’s workforce and cost pressures.
The Labor Equation
Health care is labor. Oncology, especially so.
Yet across Missouri and Kansas, workforce vacancy rates in nursing, allied health, and support roles remain stubbornly elevated. Some stabilization has occurred since the height of pandemic disruption, but turnover remains high in key categories, particularly nursing assistants and entry-level clinical roles.
The math is uncomfortable: rising patient volumes—particularly for chronic and specialty care—collide with a finite labor pool.
Main does not frame Saint Luke’s long-term workforce strategy as simply “paying more.” The system’s objective, he says, is to “deliver more.” The mechanism is care redesign—an expanded primary-care platform, deeper reliance on team-based care models, and strategic deployment of artificial intelligence tools to reduce administrative burdens on physicians and clinicians. The aim is to allow them to focus “their entire attention on patients.”
At KUCC, Beal describes a complementary approach. The center’s national reputation helps attract leading oncology talent, but he acknowledges the broader workforce challenge: demand for care is growing while the number of people entering health professions is not keeping pace. That reality is pushing systems to think earlier in the pipeline—introducing students in elementary and middle school to medical careers—and to rethink operations internally. Reducing documentation burden and tightening care coordination, he says, are essential not just for efficiency but to ensure clinicians spend their time on the right work at the right moment.
Zimmerman emphasizes retention through career advancement for bedside nurses and staff, plus robust pipeline investments. In late 2025/early 2026, HCA Midwest opened a $36.5 million expansion of Research College of Nursing, including an HCA Healthcare Center for Clinical Advancement, to train the next generation locally. The system also leads in graduate medical education, having graduated more than 200 physicians—many in primary care—who stay and practice in the region.
That philosophy reflects a broader shift. Technology—particularly AI—is increasingly viewed not as innovation theater, but as a labor-extending necessity. In an environment where hiring alone cannot close the capacity gap, systems are redesigning workflows.
The Kansas City area’s large health systems have been able to absorb some of this strain through wage increases, recruitment incentives, training partnerships and, in some cases, automation. Smaller hospitals, particularly in rural counties feeding into the metro’s tertiary centers, have less margin for error.
Workforce scarcity does more than raise costs. It reshapes access. Appointment delays lengthen. Capacity caps emerge in behavioral health and primary care. Burnout risks intensify, pushing turnover higher in a feedback loop that erodes institutional stability.
More Cases, Tighter Margins
While incidence rises, payment dynamics are becoming more volatile.
Premium increases in the individual market are accelerating in many areas as enhanced federal subsidies phase down. Employer-sponsored coverage continues to see annual increases that outpace general inflation. Out-of-pocket exposure remains high for many households, influencing when and whether patients seek care.
For insurers, the actuarial challenge is delicate. Oncology and other specialty services drive high per-member costs. Housley stresses aligning price updates with demonstrated cost trends—recognizing hospital pressures while safeguarding affordability—and collaborating on sustainable solutions that reflect modern care delivery. Blue KC has seen growth in affordable options like BlueSelect Plus networks and Spira Care products, adopted by both fully insured and self-insured employers amid shifts toward self-funding.
For hospitals, payer mix matters more
than ever. Medicare and Medicaid reimburse below commercial rates. Commercial plans negotiate aggressively, especially as employers push back on premium growth. Meanwhile, uncompensated care risks increase if coverage instability grows.
The result is a system absorbing higher clinical demand without proportional revenue expansion.
Saint Luke’s is adding capacity—in primary care and specialty lines—rather than retreating. But that expansion is disciplined. Growth is targeted to service lines where demographic demand is durable: cardiovascular disease, oncology, neurosciences. The implicit corollary is that not every service grows at the same pace.
Beal frames another pressure point: many cancer drugs and therapies rank among the most expensive treatments hospitals provide. Sustaining access, particularly in not-for-profit systems, requires continued negotiation between providers and insurers to ensure reimbursement rates that cover the cost of advanced care while maintaining affordability for patients. Collaboration, he suggests, is part
of the answer. A recently announced theranostics partnership involving The University of Kansas Health System and its medical center, Children’s Mercy Kansas City and BAMF Health aims to pool expertise in advanced diagnostic and treatment approaches—accelerating innovation while sharing capital intensity.
Zimmerman adds that his system advocates for fair, sustainable reimbursement while delivering high-value care through Sarah Cannon’s protocols, clinical trials, and nurse navigation—broadening access without compromising long-term viability.
Aging and the Youth Factor
Even with early-onset increases, the primary driver of total cancer growth remains demographic aging. Collectively, the Midwest—including Missouri and Kansas—is aging steadily. Older adults require more frequent imaging, more procedures, more medication management, more chronic-disease oversight. Medicare remains the dominant payer for many of these services.
An aging population also means rising demand for long-term care and post-acute services—sectors already grappling with workforce shortages and thin margins.
This demographic reality creates a dual burden: health systems must invest in high-tech oncology and specialty services while simultaneously sustaining geriatric, primary-care and long-term-care capacity.
It is capital-intensive at both ends of the age spectrum.
Beal adds that as treatments evolve, survivorship will become an even more visible feature of the regional landscape. With advances in cellular therapy and precision medicine, more patients will live longer beyond initial treatment. That shift moves the paradigm from simply treating cancer to managing long-term health and well-being after it—requiring coordinated follow-up, monitoring and supportive care that extend well past the acute episode.
The dip in cancer diagnoses during the initial stages of the 2020 pandemic, driven largely by deferred screenings, created a temporary distortion in trend lines. The rebound since then reflects both catch-up diagnoses and the return
of routine detection patterns.
There is no evidence in the national data of a sudden, unexplained surge beyond those dynamics. But the pandemic’s echo remains visible in stage-at-diagnosis concerns and capacity bottlenecks.
For providers, that means planning for longer-term waves—not sudden spikes. Screening campaigns, community outreach and preventive services remain essential.
The Regional Impact
If there is a unifying insight across these data points, it is this: health-care demand in the Kansas City region is structurally expanding, while the economic and labor capacity to deliver that care is structurally constrained. That tension will shape strategic decisions across the metro involving capital allocation, workforce investment, insurance design and employer engagement and technology adoption.
Kansas City’s position as a regional referral hub amplifies these dynamics. Patients from rural Missouri and Kansas flow into metro facilities for complex care. As smaller facilities struggle, that referral volume may increase, concentrating specialty demand in urban centers.
The metro’s competitive health systems will respond differently—some leaning into expansion, others emphasizing efficiency—but none can ignore the macro trend: the clinical load is growing.
For business owners and executives, the implications extend beyond hospitals. Health care is one of the Kansas City region’s largest employment sectors. Rising clinical demand can support job growth—but only if workforce pipelines keep pace. At the same time, rising insurance premiums act as a drag on wage growth and business competitiveness.
When employers spend more on health benefits, that is capital not invested in expansion, hiring or compensation. When workers face higher out-of-pocket costs, discretionary spending tightens. When hospitals devote increasing revenue to labor and specialty infrastructure, their tolerance for low-margin community services narrows.
In the end, for providers, insurers, employers and residents, health care thus operates as both growth engine and cost center within the regional economy.
